Literature DB >> 23306729

Optimisation of an automated drusen-quantifying software for the analysis of drusen distribution in patients with age-related macular degeneration.

B B Ong1, N Lee, W P Lee, E Pearce, S Sivaprasad, C C Klaver, R T Smith, N V Chong.   

Abstract

PURPOSE: The purpose of this study is to optimise the settings of the Retinal Image Analysis Laboratory (RIALAB), a semi-automatic drusen quantification software, in planning for high-throughput quantification of drusen in clinical studies of age-related macular degeneration (AMD). PATIENTS AND METHODS: A comparison of five different settings in RIALAB was made on 67 images from the Rotterdam eye study (population-based study) and 56 images from the fellow eye of patients with active neovascular AMD in King's College Hospital, London (hospital-based study).
RESULTS: The 'Few Outer' setting was the best setting, with it being most appropriate for 52 (77.6%) of the Rotterdam cohort and 47 (83.9%) for the London cohort. Pearson's χ(2)-test revealed both results to be statistically significant (P<0.0001).
CONCLUSIONS: RIALAB is a viable algorithm and software package that can detect, quantify, and analyse drusen efficiently in both population-based and hospital-based studies. We have shown that the 'Few Outer' drusen setting can be employed as the default setting, with fine-tuning only needed in a minority of cases, thus helping to speed up workflow.

Entities:  

Mesh:

Year:  2013        PMID: 23306729      PMCID: PMC3625998          DOI: 10.1038/eye.2012.292

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

1.  Detection and segmentation of drusen deposits on human retina: potential in the diagnosis of age-related macular degeneration.

Authors:  K Rapantzikos; M Zervakis; K Balas
Journal:  Med Image Anal       Date:  2003-03       Impact factor: 8.545

2.  Performance of drusen detection by spectral-domain optical coherence tomography.

Authors:  Ferdinand G Schlanitz; Christian Ahlers; Stefan Sacu; Christopher Schütze; Marcos Rodriguez; Sabine Schriefl; Isabelle Golbaz; Tobias Spalek; Geraldine Stock; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-12       Impact factor: 4.799

3.  Automated detection of macular drusen using geometric background leveling and threshold selection.

Authors:  R Theodore Smith; Jackie K Chan; Takayuki Nagasaki; Umer F Ahmad; Irene Barbazetto; Janet Sparrow; Marta Figueroa; Joanna Merriam
Journal:  Arch Ophthalmol       Date:  2005-02

4.  Drusen measurement from fundus photographs using computer image analysis.

Authors:  E Peli; M Lahav
Journal:  Ophthalmology       Date:  1986-12       Impact factor: 12.079

5.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

6.  Computer-assisted, interactive fundus image processing for macular drusen quantitation.

Authors:  D S Shin; N B Javornik; J W Berger
Journal:  Ophthalmology       Date:  1999-06       Impact factor: 12.079

7.  Incidence and progression rates of age-related maculopathy: the Rotterdam Study.

Authors:  C C Klaver; J J Assink; R van Leeuwen; R C Wolfs; J R Vingerling; T Stijnen; A Hofman; P T de Jong
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

8.  Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt disease.

Authors:  Gwenole Quellec; Stephen R Russell; Todd E Scheetz; Edwin M Stone; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-06       Impact factor: 4.799

9.  Determinants of disease and disability in the elderly: the Rotterdam Elderly Study.

Authors:  A Hofman; D E Grobbee; P T de Jong; F A van den Ouweland
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

10.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082

  10 in total
  2 in total

1.  Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software.

Authors:  Alex S Willoughby; Stephanie J Chiu; Rachel K Silverman; Sina Farsiu; Clare Bailey; Henry E Wiley; Frederick L Ferris; Glenn J Jaffe
Journal:  Transl Vis Sci Technol       Date:  2017-02-07       Impact factor: 3.283

2.  Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration.

Authors:  Thomas J Heesterbeek; Eiko K de Jong; Ilhan E Acar; Joannes M M Groenewoud; Bart Liefers; Clara I Sánchez; Tunde Peto; Carel B Hoyng; Daniel Pauleikhoff; Hans W Hense; Anneke I den Hollander
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.